See inside every stock. Pro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.75▲ 0.14%Gold spot4,012▼ 0.30%WTI103.27▲ 3.82%
← BUKA page
XStocksXray
Market X-Ray report · 23 October 2026

PT Bukalapak.com (BUKA)

Jakarta Exchange · Indonesia · prices in IDR · close of 23 Oct 2026

Key indicators

Last closeIDR 109.00
52-week range90.00 – 184.00
Return, 1 month / 3 months+1.9% / −8.4%
Return, 1 year / 3 years−35.5% / −47.6%
TrendBelow its 200-day average
RSI (14)57
Volatility (1 year)40.8%
Worst drawdown (1 year)-45.7%
Average daily value traded16,085.92M IDR
Dividend yield–

Market X-Ray price-based

53/ 100 · High confidence · ahead of 54% of stocks on this exchange
Trend41
Momentum28
Stability (higher is calmer)68
Liquidity87
Income–

Five-year price chart navy: price · brown: 200-day average

55.702394226067892021-102023-012024-042025-082026-10

About the company

PT Bukalapak.com operates an online marketplace based in Indonesia that connects small merchants and individual sellers with shoppers across the country. Its platform lets sellers open digital storefronts and offer physical goods, while also providing digital products and services such as bill payments, mobile credit and financial services to consumers. The company serves a broad base of everyday customers and small business owners, with its main operations centred in Jakarta.

The shares are listed on the Jakarta Exchange in Indonesia under the code BUKA, and the price on this page is in Indonesian rupiah (IDR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

PT Bukalapak.com (BUKA) trades on the Jakarta Exchange in Indonesia. It last closed at IDR 109.00 on 23 October 2026.

Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 428 of 923 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 35.5% and over the last three months it fell 8.4%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
PT Bukalapak.com (BUKA)

The five lenses in numbers each metric is ranked against the other stocks on Jakarta Exchange

Lens and metricValueScoreReading
Trend41 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-13.8%
From 52-week high-37.7%
Momentum28 · WeakLagging most stocks on this exchange.
3-month return-8.4%
6-month return-33.5%
12-month return, skipping the last month-36.7%
Stability (higher is calmer)68 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)40.8%
Worst drawdown, 1 year (smaller is calmer)-45.7%
Liquidity87 · StrongTrades actively.
Average daily value traded16,085.92M IDR
Zero-volume days3.3%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Liquidity: Trades actively.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.

Returns

1 week+11.2%
1 month+1.9%
3 months−8.4%
6 months−33.5%
1 year−35.5%
3 years−47.6%
5 years−83.9%

Signals

50-day / 200-day average107.16 / 126.41
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)5.74

Technical summary

DailyBullish9 bullish · 3 neutral · 4 bearish
WeeklyBearish3 bullish · 1 neutral · 8 bearish
MonthlyStrongly bearish0 bullish · 1 neutral · 7 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Jakarta Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 24 Oct 2026